Ra Medical Systems, Inc. (RMED): Price and Financial Metrics


Ra Medical Systems, Inc. (RMED): $3.02

0.08 (+2.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

RMED POWR Grades


  • Momentum is the dimension where RMED ranks best; there it ranks ahead of 72.99% of US stocks.
  • The strongest trend for RMED is in Growth, which has been heading down over the past 42 weeks.
  • RMED's current lowest rank is in the Quality metric (where it is better than 3.69% of US stocks).

RMED Stock Summary

  • RMED has a higher market value than only 1.37% of US stocks; more precisely, its current market capitalization is $21,791,258.
  • The volatility of Ra Medical Systems Inc's share price is greater than that of 94.6% US stocks with at least 200 days of trading history.
  • Ra Medical Systems Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -94.35%, greater than the shareholder yield of merely 2.07% of stocks in our set.
  • Stocks that are quantitatively similar to RMED, based on their financial statements, market capitalization, and price volatility, are FUV, IVAC, CLPS, AEHR, and KN.
  • RMED's SEC filings can be seen here. And to visit Ra Medical Systems Inc's official web site, go to www.ramed.com.

RMED Valuation Summary

  • RMED's price/sales ratio is 5.4; this is 52.42% lower than that of the median Healthcare stock.
  • RMED's price/earnings ratio has moved up 12.3 over the prior 36 months.
  • Over the past 36 months, RMED's price/earnings ratio has gone up 12.3.

Below are key valuation metrics over time for RMED.

Stock Date P/S P/B P/E EV/EBIT
RMED 2021-08-31 5.4 1.1 -0.7 -0.2
RMED 2021-08-30 5.0 1.0 -0.7 -0.1
RMED 2021-08-27 5.2 1.0 -0.7 -0.1
RMED 2021-08-26 5.0 1.0 -0.7 -0.1
RMED 2021-08-25 5.0 1.0 -0.7 -0.1
RMED 2021-08-24 4.9 1.0 -0.7 -0.1

RMED's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • RMED has a Quality Grade of F, ranking ahead of 3.87% of graded US stocks.
  • RMED's asset turnover comes in at 0.13 -- ranking 149th of 181 Medical Equipment stocks.
  • 500 - Internal server error

The table below shows RMED's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.130 -0.315 -4.443
2021-03-31 0.116 -0.270 -4.800
2020-12-31 0.115 -0.244 -3.900
2020-09-30 0.111 -0.293 -2.499
2020-06-30 0.127 -0.243 -2.111
2020-03-31 0.129 -0.244 -3.508

RMED Stock Price Chart Interactive Chart >

Price chart for RMED

RMED Price/Volume Stats

Current price $3.02 52-week high $9.82
Prev. close $2.94 52-week low $2.38
Day low $2.94 Volume 173,900
Day high $3.07 Avg. volume 2,422,644
50-day MA $3.29 Dividend yield N/A
200-day MA $5.16 Market Cap 21.23M

Ra Medical Systems, Inc. (RMED) Company Bio


RA Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is based in Carlsbad, California.


RMED Latest News Stream


Event/Time News Detail
Loading, please wait...

RMED Latest Social Stream


Loading social stream, please wait...

View Full RMED Social Stream

Latest RMED News From Around the Web

Below are the latest news stories about Ra Medical Systems Inc that investors may wish to consider to help them evaluate RMED as an investment opportunity.

Ra Medical Systems to Present at the Virtual H.C. Wainwright 23rd Annual Global Investment Conference

CARLSBAD, Calif., September 07, 2021--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing excimer laser systems to treat vascular diseases, announces that management will present at the virtual H.C. Wainwright 23rd Annual Global Investment Conference being held September 13-15, 2021. A webcast of the presentation will be available on the "News and Events" section of the company’s website beginning Monday, September 13 at 7:00 a.m. Eastern time.

Yahoo | September 7, 2021

Ra Medical To Focus On Peripheral Artery Disease With Pharos Dermatology Divestiture

Ra Medical Systems Inc (NYSE: RMED ) has sold its Pharos dermatology business to STRATA Skin Sciences Inc (NASDAQ: SSKN ) for $3.7 million in cash. The Pharos excimer laser is an FDA-cleared treatment for psoriasis, vitiligo, atopic dermatitis, and leukoderma. "We believe this transaction is in the best Full story available on Benzinga.com

Benzinga | August 17, 2021

Ra Medical Systems Reports 2021 Second Quarter Financial Results

Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on commercializing its excimer laser system to treat vascular diseas

Business Wire | August 16, 2021

Ra Medical Systems Announces Sale of Pharos Dermatology Business

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on commercializing its excimer laser system to treat vascular disease, announces the sale of its Pharos dermatology business to STRATA Skin Sciences (Nasdaq: SSKN) for $3.7 million in cash. The Pharos excimer laser is FDA-cleared for the treatment of psoriasis, vitiligo, atopic dermatitis and leukoderma. We believe this transaction is in the best interest of Ra Medical and our sh

Business Wire | August 16, 2021

Ra Medical Systems to Report Second Quarter 2021 Financial Results on August 16, 2021

CARLSBAD, Calif., August 09, 2021--Ra Medical Systems, Inc. (NYSE American: RMED) announces that it will report second quarter 2021 financial results after market close on Monday, August 16, 2021. Ra Medical management will hold an investment community conference call that day at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) to discuss financial results and provide a company update.

Yahoo | August 9, 2021

Read More 'RMED' Stories Here

RMED Price Returns

1-mo 22.27%
3-mo -42.15%
6-mo -51.45%
1-year -53.96%
3-year N/A
5-year N/A
YTD -59.35%
2020 -73.70%
2019 -85.79%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6939 seconds.